MOLECULAR-BASIS OF CROSS-REACTIVITY AND THE LIMITS OF ANTIBODY-ANTIGEN COMPLEMENTARITY

被引:154
|
作者
AREVALO, JH
TAUSSIG, MJ
WILSON, IA
机构
[1] SCRIPPS RES INST, DEPT MOLEC BIOL, LA JOLLA, CA 92037 USA
[2] AFRC, BABRAHAM INST, DEPT IMMUNOL, STRUCT STUDIES LAB, CAMBRIDGE CB2 4AT, ENGLAND
关键词
D O I
10.1038/365859a0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
TWO major unanswered questions concerning the specificity of antibodies are: how do structurally different antigens bind with high affinity to the same antibody, and what are the limits of the antibody combining site complementarity and flexibility that contribute to such crossreactivity? We report here a comparative analysis of the X-ray structures of five conformationally different steroids in complex with the Fab' fragment of an anti-progesterone antibody DB3 at 2.7 angstrom. This antibody is unable to complement completely the shape of the hydrophobic antigen so that crossreactivity occurs with other ligands without major structural rearrangements of the binding site. Antigen specificity can be explained through conserved interactions of DB3 with the steroid D-ring, whereas some of the crossreactivity is realized through different binding orientations of the steroid skeleton that place the A-ring into alternative pockets on the antibody surface. The restricted gene usage of the VGAM3.8 family in the generation of anti-progesterone monoclonal antibodies1,2 may be explained by the specific interaction Of V(H) hallmark residues with the steroid D-ring. This first detailed structure of steroid interactions with a protein could be applied to the understanding of general mechanisms of steroid recognition as well as in the design of specific binding sites for small hydrophobic ligands.
引用
收藏
页码:859 / 863
页数:5
相关论文
共 50 条
  • [31] Antigen cross-reactivity: Essential in the function of TCRs
    Mason, D
    IMMUNOLOGIST, 1998, 6 (06): : 220 - 222
  • [32] Rationalization and Design of the Complementarity Determining Region Sequences in an Antibody-Antigen Recognition Interface
    Yu, Chung-Ming
    Peng, Hung-Pin
    Chen, Ing-Chien
    Lee, Yu-Ching
    Chen, Jun-Bo
    Tsai, Keng-Chang
    Chen, Ching-Tai
    Chang, Jeng-Yih
    Yang, Ei-Wen
    Hsu, Po-Chiang
    Jian, Jhih-Wei
    Hsu, Hung-Ju
    Chang, Hung-Ju
    Hsu, Wen-Lian
    Huang, Kai-Fa
    Ma, Alex Che
    Yang, An-Suei
    PLOS ONE, 2012, 7 (03):
  • [33] Caspofungin: Cross-Reactivity in the Aspergillus Antigen Assay
    Steinmann, J.
    Buer, J.
    Rath, P. -M.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2010, 48 (06) : 2313 - 2313
  • [34] Role of cross-reactivity in the development of antibody responses
    Hodgkin, PD
    IMMUNOLOGIST, 1998, 6 (06): : 223 - 226
  • [35] Flavivirus-induced antibody cross-reactivity
    Mansfield, Karen L.
    Horton, Daniel L.
    Johnson, Nicholas
    Li, Li
    Barrett, Alan D. T.
    Smith, Derek J.
    Galbraith, Sareen E.
    Solomon, Tom
    Fooks, Anthony R.
    JOURNAL OF GENERAL VIROLOGY, 2011, 92 : 2821 - 2829
  • [36] CROSS-REACTIVITY OF IGG ANTIBODY TO REACTIVE ANHYDRIDES
    ZEISS, CR
    LEACH, CL
    HATOUM, NS
    HENDERSON, J
    PATTERSON, R
    GARVIN, PJ
    CLINICAL RESEARCH, 1988, 36 (06): : A861 - A861
  • [37] CROSS-REACTIVITY AND TRANSFER OF ANTIBODY IN TRANSPLANTATION IMMUNITY
    FUJII, G
    NELSON, RA
    JOURNAL OF EXPERIMENTAL MEDICINE, 1963, 118 (06): : 1037 - &
  • [38] Antibody Cross-Reactivity in Serodiagnosis of Lyme Disease
    Grazlewska, Weronika
    Holec-Gasior, Lucyna
    ANTIBODIES, 2023, 12 (04)
  • [39] Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxin
    Consuelo Garcia-Rodriguez
    Raphael Levy
    Joseph W Arndt
    Charles M Forsyth
    Ali Razai
    Jianlong Lou
    Isin Geren
    Raymond C Stevens
    James D Marks
    Nature Biotechnology, 2007, 25 : 107 - 116
  • [40] Antibody-based PrEP and Cross-reactivity
    Whaley, Kevin J.
    Hume, Steve
    Zeitlin, Larry
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2014, 30 : A210 - A211